Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Johnson and Johnson
Cantor Fitzgerald
Queensland Health

Generated: April 26, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,899,717

« Back to Dashboard

Summary for Patent: 6,899,717
Title: Methods and apparatus for delivery of ocular implants
Abstract:An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
Inventor(s): Weber; David (Danville, CA), Kane; Ingrid (Los Altos, CA), Rehal; Mike (Boulder Creek, CA), Lathrop, III; Robert L. (Santa Clara, CA), Aptekarev; Kenny (Santa Cruz, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/246,884
Patent Claims: 1. A method of delivering an ocular microimplant into a patient's eye comprising the steps of: (a) providing a cannula having a proximal end, a distal sharp end, and a lumen extending therethrough, a microimplant retained within the lumen, and a push rod received through the proximal end of the cannula; (b) puncturing the outer layer of a patient's eye with the cannula and inserting the cannula into a patient's eye to a desired location; (c) moving the push rod from the proximal end of the cannula toward the distal end of the cannula, thereby ejecting the microimplant from the cannula; and (d) removing the cannula and push rod from the patient's eye; wherein the puncture in the patient's eye created by the insertion of the cannula in step (c) is self-sealing upon the removal of the cannula in step (d).

2. The method of claim 1 wherein the providing step (a) further comprises providing a cannula having an outer diameter of 0.032 inches or less.

3. The method of claim 1 wherein the providing step (a) further comprises providing a cannula having an outer diameter of approximately 0.028 inches or less.

4. The method of claim 1 wherein the providing step (a) further comprises providing a cannula wherein the cannula lumen has a cross-sectional area of 0.0008 square inches or less.

5. The method of any one of claims 1-4 wherein the puncturing step (b) further comprises inserting the cannula into the patient's eye at an angle of 45.degree. or less relative to the eye surface.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.